Navigation Links
Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent
Date:12/27/2008

ST. DAVID'S, Bermuda, Dec. 23 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed lawsuits against each of Mutual Pharmaceutical Company, Inc. ("Mutual"), Mylan Pharmaceuticals Inc. ("Mylan") and Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic. Warner Chilcott markets and sells DORYX delayed-release tablets in 150, 100 and 75 mg strengths under a license agreement with Mayne.

The lawsuits are in response to the submission of Abbreviated New Drug Applications ("ANDAs") to the U.S. Food and Drug Administration ("FDA") by each of Mutual, Mylan and Impax requesting approval to manufacture and sell generic versions of DORYX 100 and 75 mg delayed-release tablets prior to the expiration in 2022 of the '161 Patent. Warner Chilcott and Mayne intend to vigorously defend the '161 Patent and pursue their legal rights.

About Warner Chilcott

Warner Chilcott is a specialty pharmaceutical company focused on developing, manufacturing, marketing and selling branded prescription pharmaceutical products in women's healthcare and dermatology in the U.S. WCRX-G.

Read more on www.warnerchilcott.com.

Warner Chilcott's Forward Looking Statements:

This press release contains forward-looking statements, including statements concerning our product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securitie
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimers and Other Cognitive Disorders
2. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
3. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
4. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
5. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
6. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
7. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
8. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
9. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
10. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
11. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Pa. , Sept. 1, 2015 ... fully integrated specialty pharmaceutical company focused on discovering, ... that researchers will be  presenting scientific data on ... an abuse-deterrent, extended-release, oral morphine product candidate, and ... development, at PainWeek 2015 to be ...
(Date:9/1/2015)... MOUNTAIN VIEW, Calif. , Sept. 1, ... of the cardiovascular image management market, Frost ... with the 2015 European Frost & Sullivan ... Netherlands -based PMI has designed innovative ... product lines—which deliver precise and reproducible quantitative ...
(Date:9/1/2015)... , September 1, 2015 BerGenBio ... today announces that it has appointed Hilde Furberg ... Directors to its Board of Directors, effective immediately. ... of experience in pharma and biotech and is currently ... Sanofi company. Previously her role was Vice President and ...
Breaking Medicine Technology:Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 2Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 3Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 4Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 5BerGenBio Appoints Non-Executive Directors 2
... Oct. 25 The National Community Pharmacists Association (NCPA) ... Digest, sponsored by Cardinal Health , which found that ... their business in 2009 despite a stagnant economy, the ... drug reimbursements and the questionable business practices of pharmacy ...
... Panasonic Corporation of North America has completed an investment ... Medical Technologies which works closely with the Texas Medical ... establish itself as a global leader in Personalized Preventive ... to establish a presence in the world,s largest medical ...
Cached Medicine Technology:NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges 2NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges 3NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges 4Panasonic Makes Investment in Houston-based CardioNexus Corp. 2Panasonic Makes Investment in Houston-based CardioNexus Corp. 3Panasonic Makes Investment in Houston-based CardioNexus Corp. 4
(Date:9/1/2015)... ... 01, 2015 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... awareness initiative, the nation’s premier and most high-profile lymphoma awareness campaign. Since its ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary Hospital hosted the 18th ... Calvary’s Camp Compass® has taken place at Kingsborough Community College in Brooklyn in each ... whom work for Calvary, and two junior counselors who were campers themselves just a ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... aid colleges and universities across the country in stemming sexual assaults on their ... Climate Collaborative (ARC3), a consortium of sexual assault researchers and student affairs professionals ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... options, Blue Cross and Blue Shield of Minnesota (Blue Cross) has announced Doctor ... , Based in San Francisco, Doctor On Demand provides immediate access to Board ...
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia ... Machine,” is still strongly maintaining her firm’s success in the hair care and ... her upcoming city-to-city tour, Ellis will be providing “Look and learn” live demonstrations, ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2
... companies to different moral standards than other organizations, according ... Consumer Research . "Imagine the CEO of ... the business of maximizing shareholder profitability and fully intends ... prices should be very high because of limited competition," ...
... bed has to deal with numerous complications. Frequently, they ... them. Bony prominences, such as the sacrum, coccyx and ... to tissue necrosis. Damage can extend into the periosteum ... are entryways for germs, which can trigger sepsis. While ...
... the US Prostate Cancer Prevention Trial found cancer in many ... debated which PSA level should lead to a biopsy recommendation. ... amid considerable controversy, that the evidence does not support recommending ... because the risks outweigh the benefits. Now, a study ...
... MONDAY, Dec. 12 (HealthDay News) -- Acupuncture may help ... to a new study. Cancer drugs called taxanes, ... especially in the calves and feet, resulting in severe ... no effective treatment for the condition, called chemotherapy induced ...
... By Steven Reinberg HealthDay Reporter , MONDAY, ... drugs for attention deficit-hyperactivity disorder (ADHD) do not seem to ... finds. There have been fears that these drugs can ... large, observational study found no evidence that these effects posed ...
... -- A 59-year-old woman from upstate New York and ... were the first patients in New York state and ... transplanted lungs that were assessed and reconditioned in the ... to dramatically increase the availability of lungs for transplant. ...
Cached Medicine News:Health News:Commercial or communal: Why is outsourcing taboo for churches and pharmaceutical companies? 2Health News:Lying and sitting more comfortably 2Health News:Biopsy referral after PSA screening stays consistent over time 2Health News:Acupuncture Might Ease Chemotherapy Pain 2Health News:ADHD Drugs Don't Raise Risk of Heart Problems: Study 2Health News:ADHD Drugs Don't Raise Risk of Heart Problems: Study 3Health News:NewYork-Presbyterian/Columbia surgeons perform first 'ex vivo' lung transplants in New York 2
Designed to determine the precise length of limbal incisions and proper alignment of closing sutures. Curved marking blade with 2 mm lines spaced 1 mm apart-measures up to 10 mm. Round knurled handle...
Measures up to 152 mm in 1 mm increments and 6 inches in 1/32 inch increments. Deeply etched graduations and dull finish....
Rigid Endoscopes....
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: